In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Summit Therapeutics Inc (NASDAQ: SMMT) closed at $18.46 down -2.53% from its previous closing price of $18.94. In other words, the price has decreased by -$2.53 from its previous closing price. On the day, 0.92 million shares were traded. SMMT stock price reached its highest trading level at $19.14 during the session, while it also had its lowest trading level at $18.4.
Ratios:
For a deeper understanding of Summit Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.31 and its Current Ratio is at 8.31. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on November 04, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $32.
On September 27, 2024, Citigroup Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $19 to $23.
On August 12, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $16.H.C. Wainwright initiated its Buy rating on August 12, 2024, with a $16 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 27 ’24 when Zanganeh Mahkam bought 54,321 shares for $3.72 per share. The transaction valued at 201,874 led to the insider holds 24,923,800 shares of the business.
Zanganeh Mahkam bought 30,000 shares of SMMT for $112,500 on Mar 26 ’24. The Chief Executive Officer now owns 30,000 shares after completing the transaction at $3.75 per share. On Mar 27 ’24, another insider, Zanganeh Mahkam, who serves as the Chief Executive Officer of the company, bought 26,000 shares for $3.72 each. As a result, the insider paid 96,720 and bolstered with 520,814 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SMMT now has a Market Capitalization of 13967259648 and an Enterprise Value of 13158894592.
Stock Price History:
Over the past 52 weeks, SMMT has reached a high of $33.89, while it has fallen to a 52-week low of $1.89. The 50-Day Moving Average of the stock is -9.22%, while the 200-Day Moving Average is calculated to be 66.16%.
Shares Statistics:
For the past three months, SMMT has traded an average of 5.14M shares per day and 1654390 over the past ten days. A total of 701.66M shares are outstanding, with a floating share count of 103.50M. Insiders hold about 85.96% of the company’s shares, while institutions hold 11.49% stake in the company. Shares short for SMMT as of 1731628800 were 15987477 with a Short Ratio of 3.11, compared to 1728950400 on 15446534. Therefore, it implies a Short% of Shares Outstanding of 15987477 and a Short% of Float of 13.459999999999999.
